Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-08-06 Purchase | 2018-08-07 4:30 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Hanlon Suzanne M. Sec, VP & General Counsel | 3,800 | $5.802 | $22,048 | 43,693 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-01-21 Option Award | 2021-01-25 4:14 pm | N/A 2031-01-21 | Zynerba Pharmaceuticals Inc. | ZYNE | Hanlon Suzanne M. Sec, VP & General Counsel | 92,000 | $0 | 135,693 (Direct) | View |
| 2020-01-30 Option Award | 2020-02-03 4:34 pm | N/A 2030-01-30 | Zynerba Pharmaceuticals Inc. | ZYNE | Hanlon Suzanne M. Sec, VP & General Counsel | 60,000 | $0 | 60,000 (Direct) | View |
| 2019-01-24 Option Award | 2019-01-28 4:20 pm | N/A 2029-01-24 | Zynerba Pharmaceuticals Inc. | ZYNE | Hanlon Suzanne M. Sec, VP & General Counsel | 52,859 | $0 | 52,859 (Direct) | View |